REPORT FROM THE 6TH WORLD STROKE CONGRESS – Approximately 1 in 5 acute stroke patients will demonstrate elevated troponin levels, which are associated with an increased risk of disability or mortality, according to a systematic review of the literature (Kerr et al. PS1).
Neurology
Unruptured intracranial aneurysms: to treat or not?
January 6, 2009REPORT FROM THE 6TH WORLD STROKE CONGRESS – Larger aneurysms and those in the posterior circulation and posterior communicating artery are at greatest risk of rupture, according to new data from the International Study of Unruptured Intracranial Aneurysms presented at the World Stroke Congress (Brown et al. Abstract FC02-04).
Read More
Anticholinergic drug use may be associated with cognitive decline
December 10, 2008REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – Anticholinergic agents (e.g. tolterodine, oxybutynin) are frequently prescribed in the elderly but may produce an accelerated cognitive decline, according to a U.S. study (Janos et al. Abstract T-35).
Read More
Earlier onset of AD in diabetes patients
December 10, 2008REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – Diabetes has been linked to cognitive decline arising from vascular damage and multi-infarct dementia, but new data suggest that diabetes may also contribute to the pathogenesis of Alzheimers disease.
MoCA useful to assess cognitive function in Parkinsons disease
December 10, 2008
Leave a reply
REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – The Montreal Cognitive Assessment (MoCA) appears to be more sensitive than the Mini Mental State Examination (MMSE) in detecting cognitive changes and may be useful in patients with Parkinsons disease.